Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Honjo Chemical is a Japanese chemical manufacturer specializing in high-purity inorganic salts and organic intermediates. Founded in 1914 and headquartered in Osaka, the company is a prominent supplier of lithium carbonate, which serves as an active pharmaceutical ingredient (API) for the treatment of bipolar disorder. The company operates manufacturing facilities in Neyagawa and Okayama, adhering to Good Manufacturing Practice (GMP) standards for its pharmaceutical products. Beyond the healthcare sector, Honjo Chemical provides essential materials for the electronics industry, including components for lithium-ion batteries and semiconductor processing. Their expertise lies in advanced purification and synthesis technologies, allowing them to produce chemicals with the extreme purity required for medical and high-tech applications. As a private entity, the company maintains a stable presence in the global fine chemicals market through its specialized product portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Honjo Chemical.